ScoutQuest14 Nov 2026
Parmax Pharma540359Board key decisions

Internal auditor appointed; board also clears state shift and Rs.50 crore limits

Parmax Pharma's board met on November 14, 2026 and approved five items.

By ScoutQuest · · 2 min read

Internal Auditor Appointed
M/s. Bakul V. Ganatra & Co, Chartered Accountants (FRN: 0100915W), for Financial Year 2026-2027
Registered Office Shift
from Gujarat to Maharashtra, with change in Memorandum of Association — subject to shareholder approval
Limit Enhancements
Rs.50 crores each for mortgage/charge on assets and for borrowings — subject to shareholder approval

Board meeting of November 14, 2026

The meeting ran from 06:30 PM to 08:00 PM IST and covered five approved items plus one agenda that was carried over.

What the board approved

Results agenda carried over

The agenda of considering and approving the un-audited financial results for the quarter and half year ended September 30, 2026 was not taken up and approved, and the board meeting was adjourned for this agenda.

What these mean for a retail investor

More numbers
  • Approved limit for mortgage or charge on assetsRs.50 crores
  • Approved borrowing limit for the BoardRs.50 crores
Source: BSE · 14 Nov 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev